These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4178461)

  • 21. Observations on the nature and significance of the long-acting thyroid stimulator.
    Brown J; Dorrington KJ; Ensor J; Smith BR; Munro DS
    Proc R Soc Med; 1968 Dec; 61(12):1301-2. PubMed ID: 4177972
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the immunological properties of LATS.
    Ochi Y; DeGroot LJ
    Endocrinology; 1968 Oct; 83(4):845-54. PubMed ID: 4176638
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the thyroid gland component inhibiting LATS.
    Schleusener H; Murthy PV; McKenzie JM
    Metabolism; 1971 Mar; 20(3):299-308. PubMed ID: 4993770
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.
    Benhamou-Glynn N; el-Kabir DJ; Roitt IM; Doniach D
    Immunology; 1969 Feb; 16(2):187-204. PubMed ID: 4181510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-acting thyroid stimulator.
    Munro DS
    Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
    [No Abstract]   [Full Text] [Related]  

  • 29. The nature and significance of the long-acting thyroid stimulator.
    Kriss J
    Adv Metab Disord; 1968; 3():209-30. PubMed ID: 4178338
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in LATS and other thyoid autoantibody levels with therapy.
    Kilpatrick JA
    N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
    [No Abstract]   [Full Text] [Related]  

  • 31. The long-acting thyroid stimulator and thyroid disease.
    Kriss JP
    Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
    [No Abstract]   [Full Text] [Related]  

  • 32. [On LATS (long-acting thyroid stimulator)].
    Miyai K
    Nihon Byori Gakkai Kaishi; 1967; 56():Suppl:379-86. PubMed ID: 4181809
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of the LATS-binding protein from human thyroid tissue.
    Smith BR; Brownstone A; Munro DS
    Proc R Soc Med; 1971 Feb; 64(2):155. PubMed ID: 5548936
    [No Abstract]   [Full Text] [Related]  

  • 34. The nature of the interaction between thyroid stimulating gamma G-globulin (long-acting thyroid stimulator) and thyroid tissue.
    Smith BR; Munro DS
    Biochim Biophys Acta; 1970 May; 208(2):285-93. PubMed ID: 5420979
    [No Abstract]   [Full Text] [Related]  

  • 35. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

  • 36. The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro.
    Smith BR
    J Endocrinol; 1970 Jan; 46(1):45-54. PubMed ID: 5412406
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
    Wong ET; Litman GW
    J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323
    [No Abstract]   [Full Text] [Related]  

  • 38. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 39. Inactivation of long-acting thyroid stimulator in vivo.
    Smith BR; Munro DS
    J Endocrinol; 1972 Jan; 52(1):189-96. PubMed ID: 5061150
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
    Beall GN; Solomon DH
    J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.